What is Carevive STAIRS and how does it impact patients and care teams?

Maddie Herzfeld, one of the co-founders of Carevive, excitedly announces the launch of Carevive STAIRS – the first-ever computerized cancer symptom pathways designed specifically for oncology nurses.

As an oncology nurse herself for the past 25 years, Maddie takes immense pride in this innovative product that empowers nurses to work at the top of their license. Carevive STAIRS, developed with input from expert oncology nurse panels across the country, enables early symptom detection and proactive management using the latest evidence, thereby preventing treatment disruptions and hospitalizations.

The product’s development was supported by the National Cancer Institute, and Carevive extends gratitude to the dedicated oncology nurses and their exceptional team who brought this groundbreaking tool to life. To see the difference Carevive STAIRS can make in your cancer program, reach out to their sales team for a demo. Get ready to elevate your patient care with Carevive STAIRS!

Recent Episodes

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…

Healthcare systems are facing a workforce crisis that’s no longer temporary—it’s structural. Even before COVID-19, staffing shortages across nursing, technical, and administrative roles were already straining capacity; today, those gaps are wider, costlier, and directly impacting patient access. With labor shortages persisting and burnout rising, health systems are being forced to rethink not just…

Healthcare systems are entering 2026 under mounting pressure. A growing, aging population and rising disease burden are colliding with persistent workforce shortages—highlighted by projections that new cancer diagnoses in the U.S. will surpass two million this year alone. The stakes are no longer theoretical: delays in care, limited specialist access, and widening disparities are…